BioCentury
ARTICLE | Strategy

Back to School 2007: Innovation & leadership

Back to School Issue

September 3, 2007 7:00 AM UTC

Over the past two years, Back to School has been exploring the relationship between innovation and the economic returns from drug development and the creation of patient value.

These discussions have argued that as pricing power wanes, a broader definition of “innovation” is required to manage economics throughout the value chain, from discovery to clinical development and into the marketplace, along with regulatory transformations, so that true innovation results in the kinds of returns commensurate with the risk involved...